Simultaneous Botox and Augmentation Injection Laryngoplasty in Patients With Adductor Spasmodic Dysphonia (ASD) and Tremor.
Abstract
[OBJECTIVE] Although Botulinum Toxin (BOTOX) is effective for adductor spasmodic dysphonia (ASD) and essential vocal tremor (EVT), the side effects of breathy dysphonia may result in reluctance to pursue BOTOX treatment. We sought to improve results in selected elderly tremor patients with EVT and in professional voice users with ASD by simultaneous BOTOX injection and injection laryngoplasty using Hyaluronic acid (HA/Botox).
[MATERIAL AND METHODS] Between July 2018 and March 2022, 23 simultaneous HA/Botox using LEMG control were done in eight patients with ASD and EVT (23 of 406 Botox Injections). All eight patients have previously reported unwanted side effects with poor voice results with Botox. Three patients had tremor with presbyphonia. Injection of Botox is performed first using LEMG control, followed by bilateral LEMG guided injection of 0.1 cc of HA.
[RESULTS] All HA/Botox injections were tolerated well. All patients reported some improved voice. Two patients did not go on to further HA injections while the others six have requested ongoing simultaneous HA/Botox injections. Patients with EVT and presbyphonia noted greater stability of voice than Botox alone. It lasted through the injection cycle. The professional voice users reported less breathy voice that allowed them to work right after the BOTOX injection.
[CONCLUSION] Simultaneous BOTOX injection with injection laryngoplasty using HA may be helpful in patients with tremor and presbyphonia. It also may be considered in professional voice users with ASD to reduce side effects of BOTOX.
[MATERIAL AND METHODS] Between July 2018 and March 2022, 23 simultaneous HA/Botox using LEMG control were done in eight patients with ASD and EVT (23 of 406 Botox Injections). All eight patients have previously reported unwanted side effects with poor voice results with Botox. Three patients had tremor with presbyphonia. Injection of Botox is performed first using LEMG control, followed by bilateral LEMG guided injection of 0.1 cc of HA.
[RESULTS] All HA/Botox injections were tolerated well. All patients reported some improved voice. Two patients did not go on to further HA injections while the others six have requested ongoing simultaneous HA/Botox injections. Patients with EVT and presbyphonia noted greater stability of voice than Botox alone. It lasted through the injection cycle. The professional voice users reported less breathy voice that allowed them to work right after the BOTOX injection.
[CONCLUSION] Simultaneous BOTOX injection with injection laryngoplasty using HA may be helpful in patients with tremor and presbyphonia. It also may be considered in professional voice users with ASD to reduce side effects of BOTOX.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botox
|
보툴리눔독소 주사 | dict | 15 | |
| 재료 | ha
|
히알루론산 | dict | 7 | |
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | EVT
→ essential vocal tremor
|
scispacy | 1 | ||
| 해부 | laryngoplasty
|
scispacy | 1 | ||
| 해부 | HA/Botox
|
scispacy | 1 | ||
| 합병증 | Adductor Spasmodic
|
scispacy | 1 | ||
| 재료 | hyaluronic acid
|
히알루론산 | dict | 1 | |
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | [MATERIAL AND
|
scispacy | 1 | ||
| 질환 | Dysphonia
|
C1527344
Dysphonia
|
scispacy | 1 | |
| 질환 | Tremor
|
C0040822
Tremor
|
scispacy | 1 | |
| 질환 | voice
|
C0042939
Voice
|
scispacy | 1 | |
| 질환 | LEMG
|
scispacy | 1 | ||
| 기타 | Patients
|
scispacy | 1 | ||
| 기타 | Toxin
|
scispacy | 1 | ||
| 기타 | Botox Injections
|
scispacy | 1 |
MeSH Terms
Humans; Botulinum Toxins, Type A; Laryngoplasty; Dysphonia; Female; Aged; Voice Quality; Male; Treatment Outcome; Hyaluronic Acid; Middle Aged; Neuromuscular Agents; Recovery of Function; Acetylcholine Release Inhibitors; Laryngeal Muscles; Injections; Aged, 80 and over; Tremor
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.